Avanos Medical (AVNS) to Release Quarterly Earnings on Tuesday

Avanos Medical (NYSE:AVNS - Get Free Report) will likely be announcing its Q1 2025 earnings results before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $161.75 million for the quarter. Avanos Medical has set its FY 2025 guidance at 1.050-1.250 EPS.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.03. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The company had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Stock Performance

Shares of AVNS traded up $0.03 during midday trading on Tuesday, reaching $12.73. 22,316 shares of the stock were exchanged, compared to its average volume of 335,980. Avanos Medical has a twelve month low of $11.84 and a twelve month high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a market cap of $585.62 million, a P/E ratio of 37.47 and a beta of 1.15. The stock's 50 day simple moving average is $13.94 and its 200 day simple moving average is $16.63.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Insider Activity at Avanos Medical

In related news, SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares of the company's stock, valued at $1,251,216.75. This represents a 7.86 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.64% of the stock is owned by insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.